Abstract Objective To study the value of amino-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting symptomatic patent ductus arteriosus (sPDA) in preterm infants. Methods Preterm infants born at a gestational age (GA) of ≤32 weeks and diagnosed with patent ductus arteriosus (PDA) by echocardiography within 48 hours after birth between June 2014 and April 2015 were selected as subjects. Their clinical manifestations were observed, and serum NT-proBNP levels were measured and echocardiography was performed at 3 and 5 days after birth. The infants were divided into sPDA group and asymptomatic PDA (asPDA) group based on their clinical manifestations and the results of echocardiography. The correlations between serum NT-proBNP level and echocardiographic indices were analyzed. Serum NT-proBNP levels were compared between the two groups. The receiver operator characteristic (ROC) curve was applied to determine the sensitivity and specificity of serum NT-proBNP in the prediction of sPDA. Results A total of 69 preterm infants were enrolled in this study, with 13 infants in the sPDA group and 56 infants in the asPDA group. Serum NT-proBNP level was positively correlated with the diameter of the arterial duct (r=0.856; Pr=0.713; PPPPConclusions NT-proBNP may be a quantitative index for shunt volume. The measurement of serum NT-proBNP levels on 3 and 5 days after birth may be useful to predict sPDA in preterm infants.
About author:: 10.7499/j.issn.1008-8830.2015.11.003
Cite this article:
LU Kai-Shan,GUO Xiao-Ling,LV Jun-Feng et al. Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants[J]. CJCP, 2015, 17(11): 1160-1164.
LU Kai-Shan,GUO Xiao-Ling,LV Jun-Feng et al. Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants[J]. CJCP, 2015, 17(11): 1160-1164.
Sellmer A, Bjerre JV, Schmidt MR, et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3[J]. Arch Dis Child Fetal Neonatal Ed, 2013, 98(6): F505-F510.
[3]
Kim JS, Shim EJ. B-type natriuretic peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants[J]. Korean Circ J, 2012, 42(3): 192-196.
[4]
Mine K, Ohashi A, Tsuji S, et al. B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants[J]. Acta Paediatr, 2013, 102(8): e347-e352.
[5]
Choi BM, Lee KH, Eun BL, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants[J]. Pediatrics, 2005, 115(3): e255-e261.
Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants[J]. Cochrane Database Syst Rev, 2013, 3: CD003951.
[10]
Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant[J]. Pediatrics, 2010, 125(5): 1020-1030.
Suzumura H, Nitta A, Tanaka G, et al. Diastolic flow velocity of the left pulmonary artery of patent ductus arteriosus in preterm infants[J]. Pediatr Int, 2001, 43(2): 146-151.
[13]
Engur D, Deveci M, Turkmen MK. Early signs that predict later haemodynamically significant patent ductus arteriosus[J]. Cardiol Young, 2015 [Epub ahead of print].
[14]
Harling S, Hansen-Pupp I, Baigi A, et al. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention[J]. Acta Paediatr, 2011, 100(2): 231-235.
[15]
Martinovici D, Vanden ES, Unger P, et al. Early NT-proBNP is able to predict spontaneous closure of patent ductus arteriosus in preterm neonates, but not the need of its treatment[J]. Pediatr Cardiol, 2011, 32(7): 953-957.
[16]
Buddhe S, Dhuper S, Kim R, et al. NT-proBNP levels improve the ability of predicting a hemodynamically significant patent ductus arteriosus in very low-birth-weight infants[J]. J Clin Neonatol, 2012, 1(2): 82-86.
Mir TS, Laux R, Hellwege HH, et al. Plasma concentrations of aminoterminal pro-atrial natriuretic peptide and aminoterminal pro-brain natriuretic peptide in healthy neonates: marked and rapid increase after birth[J]. Pediatrics, 2003, 112(4): 896-899.
[19]
Ramakrishnan S, Heung YM, Round J, et al. Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants[J]. Acta Paediatr, 2009, 98(8): 1254-1259.
